Showing results (1421-1430 of 2,428) with videos related to
Sort By:
Pageof 243
Annali Dell'Istituto Superiore Di Sanita|January 1, 1990
Perilymphatic injections of cytokines: a new tool in active cancer immunotherapy. Experimental rationale and clinical findingsG Forni, M Giovarelli, C Jemma, et al.European Urology|January 1, 1995
Local immunotherapy of superficial bladder cancer by intravesical instillation of recombinant interleukin-2A Tubaro, A Stoppacciaro, F Velotti, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 29, 2015
Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinomaRoberto Iacovelli, Daniele Santini, Mimma Rizzo, et al.Iucrj|March 10, 2020
3D-MiXD: 3D-printed X-ray-compatible microfluidic devices for rapid, low-consumption serial synchrotron crystallography data collection in flowDiana C F Monteiro, David von Stetten, Claudia Stohrer, et al.Clinical Genitourinary Cancer|May 20, 2022
A Systematic Review and Meta-Analysis of the Role of Immune Checkpoint Inhibitors (ICI) as Adjuvant Treatment for Localized High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC)Fernando Sabino M Monteiro, Andrey Soares, Vinicius Carrera Souza, et al.International Journal of Molecular Sciences|June 2, 2021
Circulating Tumor DNA Testing for Homology Recombination Repair Genes in Prostate Cancer: From the Lab to the ClinicAlessia Cimadamore, Liang Cheng, Francesco Massari, et al.Expert Review of Molecular Diagnostics|December 5, 2019
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkersAntonio Lopez-Beltran, Liang Cheng, Thomas Gevaert, et al.Future Oncology (London, England)|April 21, 2021
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic reviewAlessandro Rizzo, Veronica Mollica, Filippo Gustavo Dall'Olio, et al.Radiation Oncology (London, England)|August 19, 2016
Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: three longitudinal case studiesNoora Tuovinen, Francesco de Pasquale, Massimo Caulo, et al.Drug Design, Development and Therapy|December 22, 2025
Infusion-Related Reactions Among Cancer Patients Receiving Immune Checkpoint Inhibitors: The ARON-MOUSEION-013 Systematic Review and Meta-AnalysisElsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.Pageof 243